Next Article in Journal
Telomerase Reverse Transcriptase Increases Proliferation and Lifespan of Human NK Cells without Immortalization
Next Article in Special Issue
HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
Previous Article in Journal
Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C
Previous Article in Special Issue
NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
 
 
Review
Peer-Review Record

Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer

Biomedicines 2021, 9(6), 661; https://doi.org/10.3390/biomedicines9060661
by Doo Yong Chung 1, Jee Soo Ha 2 and Kang Su Cho 2,*
Reviewer 1:
Reviewer 2: Anonymous
Biomedicines 2021, 9(6), 661; https://doi.org/10.3390/biomedicines9060661
Submission received: 24 May 2021 / Revised: 7 June 2021 / Accepted: 7 June 2021 / Published: 9 June 2021
(This article belongs to the Special Issue Novel Strategy for Treating Castration-Resistant Prostate Cancer)

Round 1

Reviewer 1 Report

The work of Chung et coll. it is very well conducted according to international scientific criteria, on a topic of considerable clinical and oncological interest. The comparison between latest generation drugs is well represented. The tables could be graphically improved for a more immediate understanding. Furthermore, PSMA-PET is an established practice of nuclear medicine and not a new imaging modality; perhaps a PET image could have improved the quality of the work.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Interesting paper that provides data of interest in relation to the efficacy of new treatments

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop